Pasternak SH - Search Results

1

An Aspartyl Cathepsin Targeted PET Agent: Application in an Alzheimer's Disease Mouse Model.

Snir JA, Suchy M, Bindseil GA, Kovacs M, Chronik BA, Hudson RHE, Pasternak SH, Bartha R. Snir JA, et al. Among authors: pasternak sh. J Alzheimers Dis. 2018;61(3):1241-1252. doi: 10.3233/JAD-170115. J Alzheimers Dis. 2018. PMID: 29332035

2

Four-pool modeling of proton exchange processes in biological systems in the presence of MRI-paramagnetic chemical exchange saturation transfer (PARACEST) agents.

Li AX, Hudson RH, Barrett JW, Jones CK, Pasternak SH, Bartha R. Li AX, et al. Among authors: pasternak sh. Magn Reson Med. 2008 Nov;60(5):1197-206. doi: 10.1002/mrm.21752. Magn Reson Med. 2008. PMID: 18958857 Free article.

3

A paramagnetic chemical exchange-based MRI probe metabolized by cathepsin D: design, synthesis and cellular uptake studies.

Suchý M, Ta R, Li AX, Wojciechowski F, Pasternak SH, Bartha R, Hudson RH. Suchý M, et al. Among authors: pasternak sh. Org Biomol Chem. 2010 Jun 7;8(11):2560-6. doi: 10.1039/b926639a. Epub 2010 Mar 26. Org Biomol Chem. 2010. PMID: 20485791

4

Amyloid and Alzheimer's disease: inside and out.

Tam JH, Pasternak SH. Tam JH, et al. Among authors: pasternak sh. Can J Neurol Sci. 2012 May;39(3):286-98. doi: 10.1017/s0317167100013408. Can J Neurol Sci. 2012. PMID: 22547507 Review.

5

A dual magnetic resonance imaging/fluorescent contrast agent for Cathepsin-D detection.

Ta R, Suchy M, Tam JH, Li AX, Martinez-Santiesteban FS, Scholl TJ, Hudson RH, Bartha R, Pasternak SH. Ta R, et al. Among authors: pasternak sh. Contrast Media Mol Imaging. 2013 Mar-Apr;8(2):127-39. doi: 10.1002/cmmi.1502. Contrast Media Mol Imaging. 2013. PMID: 23281285 Free article.

6

Identification of Conversion from Normal Elderly Cognition to Alzheimer's Disease using Multimodal Support Vector Machine.

Zhan Y, Chen K, Wu X, Zhang D, Zhang J, Yao L, Guo X; Alzheimer’s Disease Neuroimaging Initiative. Zhan Y, et al. J Alzheimers Dis. 2015;47(4):1057-67. doi: 10.3233/JAD-142820. J Alzheimers Dis. 2015. PMID: 26401783 Free PMC article.

7

Prolonged In Vivo Retention of a Cathepsin D Targeted Optical Contrast Agent in a Mouse Model of Alzheimer's Disease.

Snir JA, Suchy M, Lawrence KS, Hudson RH, Pasternak SH, Bartha R. Snir JA, et al. Among authors: pasternak sh. J Alzheimers Dis. 2015;48(1):73-87. doi: 10.3233/JAD-150123. J Alzheimers Dis. 2015. PMID: 26401930

8

Common Variants in PLD3 and Correlation to Amyloid-Related Phenotypes in Alzheimer's Disease.

Wang C, Tan L, Wang HF, Yu WJ, Liu Y, Jiang T, Tan MS, Hao XK, Zhang DQ, Yu JT; Alzheimer's Disease Neuroimaging Initiative. Wang C, et al. J Alzheimers Dis. 2015;46(2):491-5. doi: 10.3233/JAD-150110. J Alzheimers Dis. 2015. PMID: 26402410 Free PMC article.

9

Case Report of a 63-Year-Old Patient With Alzheimer Disease and a Novel Presenilin 2 Mutation.

Wells JL, Pasternak SH. Wells JL, et al. Among authors: pasternak sh. Alzheimer Dis Assoc Disord. 2019 Apr-Jun;33(2):166-169. doi: 10.1097/WAD.0000000000000269. Alzheimer Dis Assoc Disord. 2019. PMID: 30119059 Free PMC article. No abstract available.

10

Ambroxol as a novel disease-modifying treatment for Parkinson's disease dementia: protocol for a single-centre, randomized, double-blind, placebo-controlled trial.

Silveira CRA, MacKinley J, Coleman K, Li Z, Finger E, Bartha R, Morrow SA, Wells J, Borrie M, Tirona RG, Rupar CA, Zou G, Hegele RA, Mahuran D, MacDonald P, Jenkins ME, Jog M, Pasternak SH. Silveira CRA, et al. Among authors: pasternak sh. BMC Neurol. 2019 Feb 9;19(1):20. doi: 10.1186/s12883-019-1252-3. BMC Neurol. 2019. PMID: 30738426 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

168 results

Search Page